Designed to provide additional glycemic control for patients with high blood sugar, it is essential to follow your doctors instructions carefully when using this medication
For employers that do not cover GLP-1s for weight loss but want to assist their membership, there are still options
A licensed healthcare provider will review your medical history and determine whether treatment is appropriate for you
Most summaries come in two versions
Reference comparisons: - Brand Zepbound at Eli Lilly list price: roughly $1,060/month - Brand Zepbound with Lilly savings card (commercial insurance, not covered): roughly $550/month - LillyDirect self-pay (FDA-approved Zepbound shipped directly): roughly $350-$550/month depending on dose - Commercial insurance copay for covered Zepbound (uncommon for obesity indication): roughly $25-$100/month Competitor telehealth pricing for compounded tirzepatide: - Henry Meds: roughly $300/month flat for compounded tirzepatide (verify current) - Ivim Health: roughly $270-$370/month by dose and term - Mochi Health: roughly $260-$375/month - Vitastir: roughly $200-$400/month - Form Health: roughly $350-$450/month (broader clinical scope) Hidden costs to account for when comparing Citizen Meds to alternatives: - Dose escalation charges: some providers charge a per-escalation consultation fee, others include it - Injection supplies: most providers include syringes and alcohol swabs but confirm - Cold-chain shipping surcharges in hot months or rural areas - Required lab work: some services require baseline or periodic labs at your expense Value math: If insurance covers brand Zepbound at a low copay, brand is almost always the right move: FDA-approved, stability data, standardized across every fill
Negli Stati Uniti, quasi la met dei pazienti che avevano smesso di assumere un GLP-1 RA lo aveva fatto a causa dei costi elevati del farmaco
)
